PT86821A - Process for the preparation of novel tetrazole intermediates useful for the preparation of antihypercholesterolemic compounds - Google Patents

Process for the preparation of novel tetrazole intermediates useful for the preparation of antihypercholesterolemic compounds

Info

Publication number
PT86821A
PT86821A PT86821A PT8682188A PT86821A PT 86821 A PT86821 A PT 86821A PT 86821 A PT86821 A PT 86821A PT 8682188 A PT8682188 A PT 8682188A PT 86821 A PT86821 A PT 86821A
Authority
PT
Portugal
Prior art keywords
preparation
intermediates useful
novel tetrazole
tetrazole intermediates
antihypercholesterolemic compounds
Prior art date
Application number
PT86821A
Other languages
English (en)
Other versions
PT86821B (pt
Inventor
John J Wright
Sing-Yuen Sit
Neelakantan Balasubramanian
Peter J Brown
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of PT86821A publication Critical patent/PT86821A/pt
Publication of PT86821B publication Critical patent/PT86821B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT86821A 1987-02-25 1988-02-24 Processo para a preparacao de novos compostos derivados de tetrazol utilizados como compostos intermedios na preparacao de compostos antihipercolesterolemicos PT86821B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1855887A 1987-02-25 1987-02-25
US07/151,512 US4898949A (en) 1987-02-25 1988-02-18 Intermediates for the preparation of antihypercholesterolemic tetrazole compounds

Publications (2)

Publication Number Publication Date
PT86821A true PT86821A (pt) 1988-03-01
PT86821B PT86821B (pt) 1992-05-29

Family

ID=26691250

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86821A PT86821B (pt) 1987-02-25 1988-02-24 Processo para a preparacao de novos compostos derivados de tetrazol utilizados como compostos intermedios na preparacao de compostos antihipercolesterolemicos

Country Status (27)

Country Link
US (1) US4898949A (pt)
JP (1) JP2603284B2 (pt)
KR (1) KR960007167B1 (pt)
CN (1) CN1030077C (pt)
AT (1) AT395588B (pt)
AU (1) AU610562B2 (pt)
BE (1) BE1002115A3 (pt)
CA (1) CA1328269C (pt)
CH (1) CH678182A5 (pt)
DE (1) DE3805789C2 (pt)
DK (2) DK97388A (pt)
ES (1) ES2009547A6 (pt)
FI (1) FI96600C (pt)
FR (1) FR2611201B1 (pt)
GB (1) GB2202845B (pt)
GR (1) GR1000473B (pt)
HU (3) HU201533B (pt)
IE (1) IE61608B1 (pt)
IT (1) IT1216752B (pt)
LU (1) LU87143A1 (pt)
MY (1) MY102290A (pt)
NL (1) NL8800468A (pt)
NO (1) NO178432C (pt)
NZ (1) NZ223621A (pt)
PT (1) PT86821B (pt)
SE (3) SE504553C2 (pt)
YU (1) YU46781B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
EP1054860B1 (en) * 1997-12-19 2007-04-25 Pfizer Ireland Pharmaceuticals Process for the synthesis of 1,3-diols

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
PT77996B (en) * 1983-01-24 1986-05-30 Sandoz Sa Process of the preparations of mevalonelactone analogs and derivatives thereof and of pharmaceutical compositions containing them
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
ATE62906T1 (de) * 1984-06-22 1991-05-15 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
AU601264B2 (en) * 1987-02-25 1990-09-06 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazole compounds

Also Published As

Publication number Publication date
SE504553C2 (sv) 1997-03-03
US4898949A (en) 1990-02-06
AT395588B (de) 1993-01-25
NO178432C (no) 1996-03-27
GR880100100A (en) 1988-12-16
HU201532B (en) 1990-11-28
NO178432B (no) 1995-12-18
HU895124D0 (pt) 1990-01-28
NO880802L (no) 1988-08-26
BE1002115A3 (fr) 1990-07-10
GB2202845B (en) 1991-05-22
SE9300976L (pt) 1993-03-24
GB2202845A (en) 1988-10-05
CH678182A5 (pt) 1991-08-15
CN1030077C (zh) 1995-10-18
SE9300977D0 (sv) 1993-03-24
AU610562B2 (en) 1991-05-23
FI880868A0 (fi) 1988-02-24
PT86821B (pt) 1992-05-29
FR2611201A1 (fr) 1988-08-26
DE3805789A1 (de) 1988-09-15
NL8800468A (nl) 1988-09-16
NZ223621A (en) 1991-06-25
HU201534B (en) 1990-11-28
GB8804281D0 (en) 1988-03-23
YU46781B (sh) 1994-05-10
GR1000473B (el) 1992-07-30
ES2009547A6 (es) 1989-10-01
NO880802D0 (no) 1988-02-24
HU201533B (en) 1990-11-28
FI96600B (fi) 1996-04-15
HUT47258A (en) 1989-02-28
ATA46088A (de) 1992-06-15
CN1070642A (zh) 1993-04-07
DK113897A (da) 1997-10-06
JP2603284B2 (ja) 1997-04-23
IT8819526A0 (it) 1988-02-24
SE8800637D0 (sv) 1988-02-24
JPS63290872A (ja) 1988-11-28
FI880868A7 (fi) 1988-08-26
LU87143A1 (fr) 1988-09-20
KR880009946A (ko) 1988-10-06
CA1328269C (en) 1994-04-05
SE512485C2 (sv) 2000-03-20
SE8800637L (sv) 1988-08-26
SE9300976D0 (sv) 1993-03-24
DK97388D0 (da) 1988-02-24
MY102290A (en) 1992-05-15
YU36488A (en) 1990-02-28
DE3805789C2 (de) 2001-05-31
IT1216752B (it) 1990-03-08
KR960007167B1 (ko) 1996-05-29
DK97388A (da) 1988-08-26
IE880502L (en) 1988-08-18
AU1213288A (en) 1988-09-01
FR2611201B1 (fr) 1991-01-11
SE9300977L (pt)
IE61608B1 (en) 1994-11-16
SE503201C2 (sv) 1996-04-15
FI96600C (fi) 1996-07-25

Similar Documents

Publication Publication Date Title
PT87474A (pt) Process for the preparation of pharmaceutical compounds which contain ester 1-acetoxi-ethylic of cefuroxime
DE3856515D1 (de) Zwischenprodukte zur Herstellung von benzoheterocyclischen Verbindungen
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
PT86875A (pt) Process for the preparation of phenylcarbamate
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
PT88481A (pt) Process for the preparation of a new cephem compound
GR880100101A (en) Process for the preparation of antihypercholesterolemic tetrazol compounds
FI892012A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-fenyyli-piperidiiniyhdisteiden valmistamiseksi
FI883997A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI893936A0 (fi) Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita
FI881064A7 (fi) Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FR2559487B1 (fr) Procede de preparation des organohalosilanes
PT87503A (pt) Process for the preparation of new cathecolamine by products
FI891144A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
PT87643A (pt) Process for the preparation of pyran compounds
PT86821A (pt) Process for the preparation of novel tetrazole intermediates useful for the preparation of antihypercholesterolemic compounds
GR3003256T3 (en) Process for the preparation of intermediates for the synthesis of fosfomycin
FI883589A0 (fi) Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
PT88431A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
FR2603580B1 (fr) Procede de preparation d'un compose organique polyfluorure
NO951094D0 (no) Fremgangsmåte for syntese av anvendelige mellomprodukter av substituerte imidazolforbindelser
FI922268L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911128

MM3A Annulment or lapse

Effective date: 20050530